21
- Wang LH, Huang W, Lai MD, Su IJ (2012) Aberrant cyclin A expression and centrosome
overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocar-
cinogenesis. Carcinogenesis 33:466–472 - Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L, Sun W, Ma C
(2009) Hepatitis B virus protein preS2 potentially promotes HCC development via its tran-
scriptional activation of hTERT. Gut 58:1528–1537 - Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS
(1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carci-
noma in children. Taiwan Child Hepatoma Study Group New England J Med 336:1855–1859 - Greenberg DP (1993) Pediatric experience with recombinant hepatitis B vaccines and relevant
safety and immunogenicity studies. Pediatr Infect Dis J 12:438–445 - Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, Holdaway S, Samarasinghe
D, Jackson K, Locarnini SA, Levy MT (2014) Efficacy and safety of tenofovir disoproxil fuma-
rate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol 61:502–507 - Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H,
China Study Group for the Mother-to-Child Transmission of Hepatitis B (2016) Tenofovir to
prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 374:2324–2334 - Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K,
Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study G
(2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl
J Med 351:1521–1531 - Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A (2010) Incidence of hepatocel-
lular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic
review. J Hepatol 53:348–356 - Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepato-
cellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral
therapy. J Hepatol 62:956–967
2 Hepatitis B Virus-Associated Hepatocellular Carcinoma